Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)
This study is ongoing, but not recruiting participants.
UCB Pharma SA
ReSearch Pharmaceutical Services, Inc.
Information provided by (Responsible Party):
UCB, Inc. ( UCB Pharma SA )
First received: February 1, 2012
Last updated: November 11, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||February 2014|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|